2024 annual financial data
Werewolf Therapeutics 2024 Operating margin
Direct answer
Operating margin was -3,904.19%.
Operating income was -73,594,000 USD and net income was -70,515,000 USD.
Operating cash flow was -56,188,000 USD.
Get free Werewolf Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,885,000 USD
- Operating income
- -73,594,000 USD
- Net income
- -70,515,000 USD
- Operating cash flow
- -56,188,000 USD